Concepedia
Statistics
Publications
3
Citations
65
H-Index
Active since
2016
Affiliations
Centre Hospitalier Universitaire de Toulouse(Current)
Centre de Recherches en Cancérologie de Toulouse
Institut universitaire du cancer de Toulouse Oncopole
Inserm
Université Fédérale de Toulouse Midi-Pyrénées
Sarah Figarol is an author at Centre Hospitalier Universitaire de Toulouse specializing in oncology, medicine, and molecular oncology.
Publications per year
2016–2024
The RAS‐related GTPase RHOB confers resistance to EGFR‐tyrosine kinase inhibitors in non‐small‐cell lung cancer via an AKT‐dependent mechanism
Olivier Calvayrac, Julien Mazières, Sarah Figarol et al. · EMBO Molecular Medicine · 2016 · 37 citations · Full text
Medicine, Cancer Biology, Oncology +16
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies
Sarah Figarol, Célia Delahaye, Rémi Gence et al. · Nature Communications · 2024 · 17 citations · Full text
Medicine, Oncology, Pharmacology +17
Cytoplasmic p27<sup>Kip1</sup> promotes tumorigenesis via suppression of RhoB activity
Olivier Calvayrac, Ada Nowosad, Stéphanie Cabantous et al. · The Journal of Pathology · 2018 · 11 citations
Medicine, Molecular Biology, Oncology +16
1–3 of 3